High-dose epirubicin in patients with advanced or recurrent uterine sarcoma

International Journal of Gynecological Cancer

Volumn 7, Issue 3, 1997, Pages 241-244

  Lissoni, A ^a   Cormio, G ^a,b   Colombo, N ^a   Gabriele, A ^a   Landoni, F ^a   Zanetta, G ^a   Mangioni, C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE   (Italy)

Author keywords

Epirubicin; Uterine sarcoma

Indexed keywords

EPIRUBICIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN TISSUE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; UTERUS SARCOMA; VOMITING;

EID: 0030740132     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1997.00451.x     Document Type: Article

References (11)

1. Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological Typing of Female Genital Tract Tumors, 2nd. Berlin: Springer-Verlag, 1994; 18.
2. Marchese MJ, Liskow AS, Crum CP, McCaffrey RM, Frick HC II. Uterine sarcomas: a clinicopathological study. Gynecol Oncol 1984; 18: 299-312.
3. Rose PG, Piver MS, Tsukada Y, Lan T. Patterns of metastasis in uterine sarcoma. Cancer 1989; 63: 935-8.
4. Muss HB, Bundy B, DiSaia PJ, et al. Treatment o recurrent or advanced uterine sarcoma: a randomized trial of doxorubicin versus doxorubicin and cyclophosphamide. (A phase III trial of the Gynecologic Oncology Group). Cancer 1985; 55: 1648-53.
5. Omura GA, Major FJ, Blessing JA, et al. A randomized study of Adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 1983; 52: 626-32.
6. Sutton G, Blessing JA, Rosenshein N, et al. Phase II trial of ifosfamide and mesna in mixed-mesodermal tumors of the uterus: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1989; 161: 309-12.
7. Thigpen TJ, Blessing JA, Beecham J, Homesley H, Yordan E, et al. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol 1991; 9: 1962-6.
8. Vermorken JB, Bolis G, van Rijswick A, et al. High-dose intensity regimens with epirubicin in ovarian cancer. Semin Oncol 1994; 21 (Suppl. 1): 17-22.
9. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 204-14.
10. Sutton GP, Blessing JA, Malfetano JM. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 1996; 62: 226-9.
11. Frustaci S, Foladore S, Buonadonna A, et al. Epirubicin and ifosfamide in advanced soft tissue sarcomas. Ann Oncol 1993; 4: 669-72.